Gerardus Wilhelmus van Odijk is a Dutch businessperson who has been at the helm of 6 different companies and is Chairman of Bavarian Nordic An and Chairman for Bavarian Nordic GmbH (a subsidiary of Bavarian Nordic A).

He is also on the board of Curaeos Holding BV.

He previously was Chairman-Supervisory Board for HTL-STREFA SA, Chairman-Supervisory Board of Merus NV, Senior VP & Director-Northern Europe Area at GlaxoSmithKline Plc and Principal at Glaxo, Inc. (a subsidiary of GlaxoSmithKline Plc), Principal at Glaxowellcom, Chairman for Curaeos BV and President & Chief Executive Officer at Teva Pharmaceuticals Europe BV.

Dr. Van Odijk received a doctorate from the University of Utrecht.